PubRank

Henry C Kitchener

Author PubWeight™ 48.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007 8.55
2 Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006 3.18
3 Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010 1.75
4 Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst 2012 1.68
5 Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med 2012 1.65
6 Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination. Clin Cancer Res 2004 1.51
7 Human papillomavirus and cervical cancer. Lancet 2013 1.48
8 A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BMC Public Health 2007 1.44
9 Informing adolescents about human papillomavirus vaccination: what will parents allow? Vaccine 2008 1.37
10 The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer. PLoS Genet 2012 1.33
11 Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins. Cancer Res 2003 1.24
12 Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer. Clin Cancer Res 2002 1.22
13 Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev 2012 1.16
14 Therapy of human papillomavirus-related disease. Vaccine 2012 1.11
15 Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer 2011 1.10
16 Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res 2008 1.05
17 Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev 2012 0.98
18 A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int J Cancer 2006 0.95
19 Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro. Antivir Ther 2006 0.91
20 Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia. J Gen Virol 2003 0.86
21 Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev 2009 0.86
22 Human papillomavirus in cervical screening and vaccination. Clin Sci (Lond) 2006 0.84
23 Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women. Cancer Res 2003 0.84
24 Cervical regeneration after diathermy excision of cervical intraepithelial neoplasia as assessed by transvaginal sonography. Eur J Obstet Gynecol Reprod Biol 2002 0.83
25 Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009. Int J Gynecol Cancer 2010 0.83
26 Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev 2009 0.82
27 Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev 2012 0.81
28 Cervarix--a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer. Expert Opin Biol Ther 2007 0.79
29 A prospective study of anal cancer screening in HIV-positive and negative MSM. AIDS 2016 0.78
30 Sexual behavior and HPV infection in British women, by postal questionnaires and telephone interviews. J Med Virol 2011 0.78
31 Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev 2015 0.78
32 Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study. BMC Cancer 2014 0.78
33 Human papillomavirus as a target for management, prevention and therapy. Int J Hyperthermia 2012 0.77
34 Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era. Int J Gynecol Cancer 2013 0.77
35 The second to fourth digit ratio (2D:4D) in women with and without human papillomavirus and cervical dysplasia. Am J Hum Biol 2008 0.77
36 The use of vaccines in the prevention and treatment of cervical cancer. Clin Oncol (R Coll Radiol) 2002 0.77
37 Adjuvant progestagens for endometrial cancer. Cochrane Database Syst Rev 2011 0.76
38 Photodynamic therapy of lower genital tract neoplasia. Gynecol Oncol 2002 0.75
39 The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials. Int J Gynecol Cancer 2017 0.75
40 No alteration in NK function or zeta chain expression in NK and T cells of cervical cancer patients. Gynecol Oncol 2003 0.75
41 The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials. Int J Gynecol Cancer 2017 0.75